Correlation Between Gilead Sciences and Phio Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on Gilead Sciences and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Phio Pharmaceuticals.

Diversification Opportunities for Gilead Sciences and Phio Pharmaceuticals

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Gilead and Phio is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Phio Pharmaceuticals go up and down completely randomly.

Pair Corralation between Gilead Sciences and Phio Pharmaceuticals

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.18 times more return on investment than Phio Pharmaceuticals. However, Gilead Sciences is 5.55 times less risky than Phio Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about -0.03 per unit of risk. If you would invest  7,905  in Gilead Sciences on September 13, 2024 and sell it today you would earn a total of  1,329  from holding Gilead Sciences or generate 16.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Gilead Sciences  vs.  Phio Pharmaceuticals Corp

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent essential indicators, Gilead Sciences may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phio Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Gilead Sciences and Phio Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and Phio Pharmaceuticals

The main advantage of trading using opposite Gilead Sciences and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.
The idea behind Gilead Sciences and Phio Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing